Misdiagnosis and delayed diagnosis are common among people with lung cancer-associated Lambert-Eaton myasthenic syndrome (LEMS), according to a small study in…
Articles by Marta Figueiredo, PhD
Legislation to create a Rare Disease Advisory Council (RDAC) in Colorado has passed the state’s Senate and House and was…
Leaders of the U.S. House Energy and Commerce Committee and two senators have taken action to clarify the original intent…
Blood levels of long non-coding RNA LOC338963 and its potential target AP3B2 — a protein in nerve cells — are…
Since late November and embracing the holiday spirit, the National Organization for Rare Disorders (NORD) has been sharing a…
Health Canada has re-issued its approval of Ruzurgi (amifampridine) for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 and…
Plasmapheresis, or plasma exchange, may be an effective way of managing small cell lung cancer-associated Lambert-Eaton myasthenic syndrome (LEMS)…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
The first wave of COVID-19 in Europe severely disrupted access to care and raised stress and anxiety in people with…
Lambert‐Eaton myasthenic syndrome-associated diaphragm weakness and subsequent respiratory problems may impair heart function, a case study shows. The report,…